Related references
Note: Only part of the references are listed.Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma
Bruce D. Cheson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mediastinal gray zone lymphoma - The missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma
A Traverse-Glehen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated-with CHOP or MACOP-B/VACOP-B
G Todeschini et al.
BRITISH JOURNAL OF CANCER (2004)
Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma
KR Calvo et al.
ADVANCES IN ANATOMIC PATHOLOGY (2004)
CD23 expression in mediastinal large B-cell lymphomas
M Calaminici et al.
HISTOPATHOLOGY (2004)
Part II: Hodgkin's lymphoma - diagnosis and treatment
V Diehl et al.
LANCET ONCOLOGY (2004)
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
CS Portlock et al.
ANNALS OF ONCOLOGY (2004)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
Share Paper
